Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
NCT07744737
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
34
Enrollment
OTHER
Sponsor class
Conditions
DLBCL - Diffuse Large B Cell Lymphoma
R-CHOP Chemotherapy
Pirtobrutinib
Interventions
DRUG:
Pirtobrutinib plus R-CHOP
Sponsor
Changzhou No.2 People's Hospital